Ani Pharmaceuticals Inc
ANIP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001023024
In the last 90 days, Ani Pharmaceuticals Inc insiders filed 0 open-market purchases and 10 sales; 307 institutions reported holding it in 13F filings for Q2 2026, worth $1.90B in total; no superinvestor holds it.
Holders of 5% or more of ANIP
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Ani Pharmaceuticals Inc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 12.80%2.90M shares | +1.50 ppfrom 11.30% | Oct 17, 20252 filings | Jul 27, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
12 Schedule 13D and 13G filings on Ani Pharmaceuticals Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jul 27, 20264:25 PM ET | BlackRock, Inc. | 13G/A | 12.80%2.90M shares | +1.50 ppfrom 11.30% | Jun 30, 2026 | SEC |
| Mar 26, 20263:46 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Nov 13, 20254:28 PM ET | Integrated Core Strategies (US) LLCand 3 others | 13G/A | 0.30%65.2K shares | −4.90 ppfrom 5.20%Below 5% | Sep 30, 2025 | SEC |
| Oct 17, 20256:05 PM ET | BlackRock, Inc. | 13G/A | 11.30%2.52M shares | – | Sep 30, 2025 | SEC |
| Aug 22, 20258:00 AM ET | Meridian Venture Partners II GP, L.P.and 3 others | 13D/A | 4.80%1.03M shares | −0.60 ppfrom 5.40%Below 5% | Aug 21, 2025 | SEC |
| Jun 4, 20254:00 PM ET | Integrated Core Strategies (US) LLCand 3 others | 13G | 5.20%1.12M shares | New | May 30, 2025 | SEC |
| Apr 10, 20254:00 PM ET | Millennium Management LLCand 2 others | 13G/A | 3.80%818.3K shares | −1.40 ppfrom 5.20%Below 5% | Mar 31, 2025 | SEC |
| Mar 13, 20258:50 PM ET | Meridian Venture Partners II GP, L.P.and 3 others | 13D/A | 5.40%1.18M shares | – | Mar 11, 2025 | SEC |
| Jan 21, 20254:04 PM ET | Millennium Management LLCand 2 others | 13G | 5.20%1.09M shares | New | Jan 14, 2025 | SEC |
| Mar 2, 2022 | Esjay LLC | 13DOld format | – | New | – | SEC |
| Feb 7, 20224:41 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 26, 20216:52 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Ani Pharmaceuticals Inc shares.
No Form 144 notices for Ani Pharmaceuticals Inc are on file.